This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
UK-based Small Pharma has launched on the Toronto’s TSX Venture Exchange, raising 58 million Canadian dollars (around £34m) to develop medicines based on N,N-dimethyltriptylene (DMT) to treat depression. The post Small Pharma stock market launch funds DMT-based depression drugtrial appeared first on.
TWO US clinical investigator sites have been opened for a phase 1 clinicaltrial for patients with soft tissue sarcoma and the first patient has been dosed.
A survey of members of the Raremark community found that 86% of respondents were interested in taking part in a clinicaltrial now or in the future. Research and development will always be important to rare disease patients. This is a key reason why patients view the continued progress of research and development as important.
Historically, racial and ethnically minoritized groups or populations have been excluded from clinicaltrials, leading to a lack of data on how different demographic subgroups respond to treatments. It also develops trust in clinicaltrials results and facilitates uptake if a medical product is approved,” Mervin-Blake noted.
(CDS), a leading technology provider focused on data collection and clinicaltrial management, today announced several updates in celebration of its tenth anniversary, including the company’s latest technological development, TrialKit AI, a machine-learning API. 888) 753-4777 carley.nolan@crucialdatasolutions.com.
China’s Kintor Pharmaceutical has begun late-stage US clinicaldevelopment of its potential COVID drug proxalutamide – but there is scepticism over the company’s claims about its research. The post Scepticism in press over Kintor’s COVID-19 US drugtrial appeared first on.
As the industry focuses on creating a more holistic, inclusive patient experience, here are key steps to consider in order to help bridge the gap between clinical research and the patient experience. The fact is, many minorities never learn about vital clinicaltrials in play, or that they’re eligible to participate.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content